| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
3 companies
Rachelle Suzanne Jacques is Chief Executive Officer at AKTX and has filed Form 4s across 3 companies. Rachelle Suzanne Jacques's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.3B at current prices.
Historically, Rachelle Suzanne Jacques's trades have earned a below-average insider score of 45/100 across 5 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -14.3%.
The biggest single holding is AKTX (~$8.3B) as Chief Executive Officer.
Rachelle Suzanne Jacques has 21 Form 4 filings on record from April 2019 to June 2026, across 3 companies: Director at uniQure (QURE), 2021–2026; Director at Corbus Pharmaceuticals (CRBP), 2019–2026; Chief Executive Officer at Akari Therapeutics (AKTX), 2024.
The 32 reported transactions were 17 option or other derivative awards, 10 stock awards and 5 open-market sales.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $147K.
The largest open-market sale was 1,993 shares of QURE at an average $27.06 on June 11, 2026, about $54K.
None of the 4 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | QURE Uniqure N.V. | Director | Sell | 1,993 | $27.06 | $53,930.58 | -5.6% | +71.5% | - | |
| Jun 20, 2025 | QURE Uniqure N.V. | Director | Sell | 2,112 | $14.45 | $30,518.40 | -6.9% | +3.7% | +212.4% | |
| Jun 13, 2024 | QURE Uniqure N.V. | Director | Sell | 2,221 | $5.14 | $11,415.94 | -13.4% | +4.2% | +192.2% | |
| Jun 16, 2023 | QURE Uniqure N.V. | Director | Sell | 2,301 | $18.76 | $43,166.76 | -12.2% | -60.6% | -74.9% | |
| Feb 27, 2023 | QURE Uniqure N.V. | Director | Sell | 384 | $20.02 | $7,687.68 | -3.6% | -8.4% | -67.9% |